Delivery Order SPE2DB20D1047-SPE2DB25FF81B
- Not listed
- The Defense Logistics Agency awarded a $11,557.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $5,420.66 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not set aside for small business or other designees and represents a competitively awarded transaction under the company's...
- The Defense Logistics Agency awarded a $1,220.03 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This firm fixed-price, non-set-aside contract is scheduled for completion by July 17, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a critical pharmaceutical supply for military and federal healthcare systems...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.14 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The contract represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $14,738.91. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance completion targeted for August 7, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a contract value of $6,473.57 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $31,145.42 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $10,014.11 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF81BDelivery Order
The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs and enables AmerisourceBergen to deliver a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The award of this insulin product delivery reflects AmerisourceBergen's established capability to supply critical diabetes medications and other pharmaceutical commodities through the DLA's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 9/3/25 |